- Increases 2013 Normalized FFO Guidance -
MURFREESBORO, Tenn.--(BUSINESS WIRE)--
National Health Investors, Inc. (NYSE:NHI) announced today its
normalized Funds From Operations (“FFO”), its normalized Funds Available
for Distribution ("FAD") and net income attributable to common
stockholders for the three and nine months ended September 30, 2013.
Year-To-Date Highlights
-
Increased third quarter Normalized FFO 17.2% over the same quarter in
2012
-
Closed or announced over $258 million of new investments
-
Amended and expanded an unsecured credit facility of $370 million
consisting of $250 million revolving credit facility and $120 million
of 7-year term loans
Financial Results
Normalized FFO for the three months ended September 30, 2013, was
$26,193,000, or $0.94 per diluted common share, compared with
$22,357,000, or $0.80 per diluted common share, for the same period in
2012, an increase of 17.2%. Normalized FAD for the three months ended
September 30, 2013, was $25,359,000 or $0.91 per diluted common share,
compared with $21,736,000 or $0.78 per diluted common share for the same
period in 2012, an increase of 16.7%. Normalized FFO and Normalized FAD
for the quarter ended September 30, 2013 excludes a $2,061,000 recovery
of a previous write-down on a mortgage note receivable.
FFO, as defined by the National Association of Real Estate Investment
Trusts (“NAREIT”), for the three months ended September 30, 2013, was
$28,254,000, or $1.01 per diluted common share, compared with
$19,860,000, or $0.71 per diluted common share, for the same period in
2012. Net income attributable to common stockholders for the three
months ended September 30, 2013, was $42,744,000, or $1.53 per diluted
common share, compared with $14,351,000, or $0.52 per diluted common
share, for the same period in 2012. Net income for the three months
ended September 30, 2013 includes a gain $19,370,000 on the sale of real
estate.
Normalized FFO for the nine months ended September 30, 2013, was
$74,188,000, or $2.66 per diluted common share, compared with
$65,118,000, or $2.34 per diluted common share, for the same period in
2012, an increase of 13.9%. Normalized FAD for the nine months ended
September 30, 2013, was $73,557,000 or $2.64 per diluted common share,
compared with $64,829,000 or $2.33 per diluted common share for the same
period in 2012, an increase of 13.5%. Normalized FFO and Normalized FAD
for the nine months ended September 30, 2013 excludes net loan
impairments of $1,976,000 and the effects of $561,000 in acquisition and
debt issuance costs expensed in 2013.
FFO, as defined by NAREIT, for the nine months ended September 30, 2013,
was $71,651,000, or $2.57 per diluted common share, compared with
$61,206,000, or $2.20 per diluted common share, for the same period in
2012. Net income attributable to common stockholders for the nine months
ended September 30, 2013, was $78,408,000, or $2.81 per diluted common
share, compared with $49,628,000, or $1.78 per diluted common share, for
the same period in 2012. Net income for the nine months ended September
30, 2013 includes a gain $19,370,000 on the sale of real estate.
The reconciliations of net income attributable to common stockholders to
our FFO, Normalized FFO, FAD and Normalized FAD are included as tables
to this press release and in supplemental data furnished on Form 8-K and
are filed in our Form 10-Q with the Securities and Exchange Commission.
2013 Guidance -
The Company currently forecasts Normalized FFO for 2013 from $3.53 to
$3.55 per diluted common share. The Company's guidance range for the
full year 2013 for Normalized FFO per share, with underlying assumptions
and timing of certain transactions, is set forth and reconciled below:
|
|
|
|
|
|
|
|
Full-Year 2013 Range
|
| | | | | | | |
Low
|
|
|
|
|
|
|
High
|
|
Net income per diluted share attributable to common stockholders
| | | | | | | |
$
|
3.50
| |
|
|
|
|
|
|
$
|
3.51
| |
|
Less: Gain on sale of real estate
| | | | | | | |
(.69
|
)
| | | | | | |
(.69
|
)
|
|
Plus: Real estate depreciation
| | | | | | | |
.65
| | | | | | | |
.66
| |
|
Plus: Loan impairments, net
| | | | | | | |
.07
|
| | | | | | |
.07
|
|
| Normalized FFO per diluted common share | | | | | | | | $ | 3.53 |
| | | | | | | $ | 3.55 |
|
| | | | | | | | | | | | | | | | | | |
|
The Company's guidance range reflects the existence of volatile economic
conditions, but does not assume any material deterioration in tenant
credit quality and/or performance of its portfolio. The guidance is
based on a number of assumptions, many of which are outside the
Company's control and all of which are subject to change. The guidance
range assumes selected adjustments to the Company's portfolio, the
recently announced transactions and increased general and administrative
costs in the fourth quarter. New investments during the remainder of
2013, if any, are expected to be funded with liquid investments and by
short-term and long-term debt financing. NHI's guidance may change if
actual results vary from these assumptions.
Investor Conference Call and Webcast
NHI will host a conference call on Tuesday, November 5, 2013, at 9 a.m.
ET, to discuss third quarter results. The number to call for this
interactive teleconference is (212) 231-2937 with the confirmation
number, 21680900. The live broadcast of NHI's quarterly conference call
will be available online at www.nhireit.com.
The online replay will follow shortly after the call and continue for
approximately 90 days.
About National Health Investors
National Health Investors, Inc. (NYSE: NHI), a Maryland corporation
incorporated and publicly listed in 1991, is a healthcare real estate
investment trust (REIT) specializing in financing healthcare real estate
by purchase and leaseback transactions, RIDEA transactions and by
mortgage loans. NHI’s investments include senior housing (assisted
living, memory care, independent living and senior living campuses),
skilled nursing, medical office buildings and specialty hospitals. www.nhireit.com
Statements in this press release that are not historical facts are
forward-looking statements. NHI cautions investors that any
forward-looking statements may involve risks and uncertainties and are
not guarantees of future performance. All forward-looking statements
represent NHI's judgment as of the date of this release.Investors
are urged to carefully review and consider the various disclosures made
by NHI in its periodic reports filed with the Securities and Exchange
Commission, including the risk factors and other information disclosed
in NHI's Annual Report on Form 10-K for the most recently ended fiscal
year. Copies of these filings are available at no cost on the SEC's web
site at www.sec.gov
or on NHI's web site at www.nhireit.com.
| Reconciliation of Funds From Operations and Normalized Funds From
Operations(1)(2) |
| (in thousands, except share and per share amounts) |
| |
|
| |
|
| |
|
| |
|
| |
| | | |
Three Months Ended
| | |
Nine Months Ended
|
| | | | September 30,
| | | September 30,
|
| | | |
2013
| | |
2012
| | |
2013
| | |
2012
|
|
Net income attributable to common stockholders
| | |
$
|
42,744
| | | |
$
|
14,351
| | | |
$
|
78,408
| | | |
$
|
49,628
| |
|
Elimination of certain non-cash items in net income:
| | | | | | | | | | | | |
|
Real estate depreciation in continuing operations
| | |
5,079
| | | |
5,408
| | | |
12,947
| | | |
11,275
| |
|
Real estate depreciation related to noncontrolling interest
| | |
(199
|
)
| | |
—
| | | |
(334
|
)
| | |
—
| |
|
Real estate depreciation in discontinued operations
| | |
—
| | | |
101
| | | |
—
| | | |
303
| |
|
Net gain on sales of real estate
| | |
(19,370
|
)
| | |
—
|
| | |
(19,370
|
)
| | |
—
|
|
|
Funds from operations
| | |
$
|
28,254
| | | |
$
|
19,860
| | | |
$
|
71,651
| | | |
$
|
61,206
| |
|
Gains on sales of marketable securities
| | |
—
| | | |
—
| | | |
—
| | | |
(30
|
)
|
|
Loan costs expensed due to credit facility amendment
| | |
—
| | | |
—
| | | |
353
| | | |
—
| |
|
Non-cash write-off of straight-line rent receivable
| | |
—
| | | |
—
| | | |
—
| | | |
963
| |
|
Write-offs and expenses due to early lease termination
| | |
—
| | | |
—
| | | |
—
| | | |
297
| |
|
Acquisition costs under business combination accounting
| | |
—
| | | |
—
| | | |
208
| | | |
—
| |
|
Legal settlement
| | |
—
| | | |
275
| | | |
—
| | | |
365
| |
|
Loan impairments and (recoveries), net
| | |
(2,061
|
)
| | |
2,300
| | | |
1,976
| | | |
2,300
| |
|
Other items
| | |
—
|
| | |
(78
|
)
| | |
—
|
| | |
17
|
|
|
Normalized FFO
| | |
$
|
26,193
|
| | |
$
|
22,357
|
| | |
$
|
74,188
|
| | |
$
|
65,118
|
|
| | | | | | | | | | | | |
|
| BASIC | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | |
27,876,176
| | | |
27,830,311
| | | |
27,872,805
| | | |
27,799,750
| |
|
FFO per common share
| | |
$
|
1.01
| | | |
$
|
.71
| | | |
$
|
2.57
| | | |
$
|
2.20
| |
|
Normalized FFO per common share
| | |
$
|
.94
| | | |
$
|
.80
| | | |
$
|
2.66
| | | |
$
|
2.34
| |
| | | | | | | | | | | | |
|
| DILUTED | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | |
27,905,545
| | | |
27,862,582
| | | |
27,906,914
| | | |
27,828,879
| |
|
FFO per common share
| | |
$
|
1.01
| | | |
$
|
.71
| | | |
$
|
2.57
| | | |
$
|
2.20
| |
|
Normalized FFO per common share
| | |
$
|
.94
| | | |
$
|
.80
| | | |
$
|
2.66
| | | |
$
|
2.34
| |
| | | | | | | | | | | | |
|
| | | | | | | | | | | | |
|
(1) | Management believes that funds from operations (FFO) is an
important supplemental measure of operating performance for a real
estate investment trust. Because the historical cost accounting
convention used for real estate assets requires straight-line
depreciation (except on land), such accounting presentation
implies that the value of real estate assets diminishes
predictably over time. Since real estate values instead have
historically risen and fallen with market conditions,
presentations of operating results for a real estate investment
trust that uses historical cost accounting for depreciation could
be less informative, and should be supplemented with a measure
such as FFO. The term FFO was designed by the real estate
investment trust industry to address this issue. Our measure may
not be comparable to similarly titled measures used by other
REITs. Consequently, our funds from operations may not provide a
meaningful measure of our performance as compared to that of other
REITs. Since other REITs may not use our definition of FFO,
caution should be exercised when comparing our FFO to that of
other REITs. FFO does not represent cash generated from operating
activities in accordance with GAAP (funds from operations does not
include changes in operating assets and liabilities) and therefore
should not be considered an alternative to net earnings as an
indication of operating performance, or to net cash flow from
operating activities as determined by GAAP in the United States,
as a measure of liquidity and is not necessarily indicative of
cash available to fund cash needs. |
| | | | | | | | | | | | |
|
(2) | Normalized FFO excludes from FFO certain items which, due to
their infrequent or unpredictable nature, may create some
difficulty in comparing FFO for the current period to similar
prior periods, and may include, but are not limited to, impairment
of assets, gains and losses attributable to the acquisition and
disposition of assets and liabilities, recoveries of previous
write-downs, and changes in the fair value of interest rate swap
agreements. |
|
|
| Reconciliation of Funds Available for Distribution and Normalized
Funds Available for Distribution(1)(2) |
| (in thousands, except share and per share amounts) |
| |
|
| |
|
| |
|
| |
|
| |
| | | |
Three Months Ended
| | |
Nine Months Ended
|
| | | | September 30,
| | | September 30,
|
| | | |
2013
| | |
2012
| | |
2013
| | |
2012
|
|
Net income attributable to common stockholders
| | |
$
|
42,744
| | | |
$
|
14,351
| | | |
$
|
78,408
| | | |
$
|
49,628
| |
|
Elimination of certain non-cash items in net income:
| | | | | | | | | | | | |
|
Depreciation in continuing operations
| | |
5,732
| | | |
5,791
| | | |
14,705
| | | |
12,350
| |
|
Depreciation related to noncontrolling interest
| | |
(226
|
)
| | |
—
| | | |
(401
|
)
| | |
—
| |
|
Depreciation in discontinued operations
| | |
—
| | | |
101
| | | |
—
| | | |
303
| |
|
Net gain on sales of real estate
| | |
(19,370
|
)
| | |
—
| | | |
(19,370
|
)
| | |
—
| |
|
Straight-line lease revenue, net
| | |
(1,713
|
)
| | |
(1,248
|
)
| | |
(4,408
|
)
| | |
(2,325
|
)
|
|
Non-cash stock based compensation
| | |
253
|
| | |
244
|
| | |
2,086
|
| | |
1,924
|
|
|
Funds available for distribution
| | |
$
|
27,420
| | | |
$
|
19,239
| | | |
$
|
71,020
| | | |
$
|
61,880
| |
|
Gains on sales of marketable securities
| | |
—
| | | |
—
| | | |
—
| | | |
(30
|
)
|
|
Loan costs expensed due to credit facility amendment
| | |
—
| | | |
—
| | | |
353
| | | |
—
| |
|
Write-offs and expenses due to early lease termination
| | |
—
| | | |
—
| | | |
—
| | | |
297
| |
|
Acquisition costs under business combination accounting
| | |
—
| | | |
—
| | | |
208
| | | |
—
| |
|
Legal settlement
| | |
—
| | | |
275
| | | |
—
| | | |
365
| |
|
Loan impairments and (recoveries), net
| | |
(2,061
|
)
| | |
2,300
| | | |
1,976
| | | |
2,300
| |
|
Other items
| | |
—
|
| | |
(78
|
)
| | |
—
|
| | |
17
|
|
|
Normalized FAD
| | |
$
|
25,359
|
| | |
$
|
21,736
|
| | |
$
|
73,557
|
| | |
$
|
64,829
|
|
| | | | | | | | | | | | |
|
| BASIC | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | |
27,876,176
| | | |
27,830,311
| | | |
27,872,805
| | | |
27,799,750
| |
|
FAD per common share
| | |
$
|
.98
| | | |
$
|
.69
| | | |
$
|
2.55
| | | |
$
|
2.23
| |
|
Normalized FAD per common share
| | |
$
|
.91
| | | |
$
|
.78
| | | |
$
|
2.64
| | | |
$
|
2.33
| |
| | | | | | | | | | | | |
|
| DILUTED | | | | | | | | | | | | |
|
Weighted average common shares outstanding
| | |
27,905,545
| | | |
27,862,582
| | | |
27,906,914
| | | |
27,828,879
| |
|
FAD per common share
| | |
$
|
.98
| | | |
$
|
.69
| | | |
$
|
2.54
| | | |
$
|
2.22
| |
|
Normalized FAD per common share
| | |
$
|
.91
| | | |
$
|
.78
| | | |
$
|
2.64
| | | |
$
|
2.33
| |
| | | | | | | | | | | | |
|
| | | | | | | | | | | | |
|
(1) | Management believes that FAD and normalized FAD are important
supplemental measures of a REIT’s net earnings available to common
stockholders. Since other REITs may not use our definition of FAD;
caution should be exercised when comparing our FAD to that of
other REITs. FAD in and of itself does not represent cash
generated from operating activities in accordance with GAAP (FAD
does not include changes in operating assets and liabilities) and
therefore should not be considered an alternative to net earnings
as an indication of operating performance, or to net cash flow
from operating activities as determined by GAAP as a measure of
liquidity, and is not necessarily indicative of cash available to
fund cash needs. |
| | | | | | | | | | | | |
|
(2) | Normalized FAD excludes from FAD certain items which, due to
their infrequent or unpredictable nature, may create some
difficulty in comparing FAD for the current period to similar
prior periods, and may include, but are not limited to, impairment
of assets, gains and losses attributable to the acquisition and
disposition of assets and liabilities, recoveries of previous
write-downs, and changes in the fair value of interest rate swap
agreements. |
|
|
| |
|
| |
|
| |
|
| |
| Condensed Statements of Income |
| (in thousands, except share and per share amounts) |
| | | | | | | | | | | |
|
| | |
Three Months Ended
| | |
Nine Months Ended
|
| | | September 30,
| | | September 30,
|
| | |
2013
| | |
2012
| | |
2013
| | |
2012
|
| | |
(unaudited)
| | | | | | |
|
Revenues:
| | | | | | | | | | | | |
|
Rental income
| | |
$
|
28,817
| | | |
$
|
21,116
| | | |
$
|
78,879
| | | |
$
|
61,333
|
|
Interest income from mortgage and other notes
| | |
1,936
| | | |
1,879
| | | |
5,877
| | | |
5,428
|
|
Investment income and other
| | |
1,040
|
| | |
1,348
|
| | |
3,156
|
| | |
3,462
|
| | |
31,793
|
| | |
24,343
|
| | |
87,912
|
| | |
70,223
|
|
Expenses:
| | | | | | | | | | | | |
|
Depreciation
| | |
5,732
| | | |
5,791
| | | |
14,705
| | | |
12,350
|
|
Interest
| | |
3,290
| | | |
854
| | | |
6,011
| | | |
2,176
|
|
Legal
| | |
55
| | | |
205
| | | |
621
| | | |
424
|
|
Franchise, excise and other taxes
| | |
80
| | | |
271
| | | |
316
| | | |
626
|
|
General and administrative
| | |
1,757
| | | |
1,639
| | | |
7,171
| | | |
6,018
|
|
Loan and realty (recoveries) losses, net
| | |
(2,061
|
)
| | |
2,300
|
| | |
1,976
|
| | |
2,300
|
| | |
8,853
|
| | |
11,060
|
| | |
30,800
|
| | |
23,894
|
Income before equity-method investee, discontinued operations
| | | | | | | | | | | | |
|
and noncontrolling interest
| | |
22,940
| | | |
13,283
| | | |
57,112
| | | |
46,329
|
|
Income from equity-method investee
| | |
178
| | | |
—
| | | |
269
| | | |
—
|
|
Investment and other gains
| | |
—
|
| | |
—
|
| | |
—
|
| | |
30
|
|
Income from continuing operations
| | |
23,118
| | | |
13,283
| | | |
57,381
| | | |
46,359
|
|
Discontinued operations
| | | | | | | | | | | | |
|
Income from operations - discontinued
| | |
562
| | | |
1,068
| | | |
2,321
| | | |
3,269
|
|
Gain on sale of real estate
| | |
19,370
|
| | |
—
|
| | |
19,370
|
| | |
—
|
|
Income from discontinued operations
| | |
19,932
|
| | |
1,068
|
| | |
21,691
|
| | |
3,269
|
|
Net income
| | |
43,050
| | | |
14,351
| | | |
79,072
| | | |
49,628
|
|
Net income attributable to noncontrolling interest
| | |
(306
|
)
| | |
—
|
| | |
(664
|
)
| | |
—
|
|
Net income attributable to common stockholders
| | |
$
|
42,744
|
| | |
$
|
14,351
|
| | |
$
|
78,408
|
| | |
$
|
49,628
|
| | | | | | | | | | | |
|
|
Weighted average common shares outstanding:
| | | | | | | | | | | | |
|
Basic
| | |
27,876,176
| | | |
27,830,311
| | | |
27,872,805
| | | |
27,799,750
|
|
Diluted
| | |
27,905,545
| | | |
27,862,582
| | | |
27,906,914
| | | |
27,828,879
|
| | | | | | | | | | | |
|
|
Earnings per common share:
| | | | | | | | | | | | |
|
Basic:
| | | | | | | | | | | | |
|
Income from continuing operations attributable to common stockholders
| | |
$
|
.82
| | | |
$
|
.48
| | | |
$
|
2.03
| | | |
$
|
1.66
|
|
Discontinued operations
| | |
.71
|
| | |
.04
|
| | |
.78
|
| | |
.12
|
|
Net income attributable to common stockholders
| | |
$
|
1.53
|
| | |
$
|
.52
|
| | |
$
|
2.81
|
| | |
$
|
1.78
|
| | | | | | | | | | | |
|
|
Diluted:
| | | | | | | | | | | | |
|
Income from continuing operations attributable to common stockholders
| | |
$
|
.82
| | | |
$
|
.48
| | | |
$
|
2.03
| | | |
$
|
1.66
|
|
Discontinued operations
| | |
.71
|
| | |
.04
|
| | |
.78
|
| | |
.12
|
|
Net income attributable to common stockholders
| | |
$
|
1.53
|
| | |
$
|
.52
|
| | |
$
|
2.81
|
| | |
$
|
1.78
|
| | | | | | | | | | | |
|
|
Regular dividends declared per common share
| | |
$
|
.735
| | | |
$
|
.67
| | | |
$
|
2.165
| | | |
$
|
1.97
|
|
|
|
| |
|
|
| |
| Selected Balance Sheet Data |
| (in thousands) |
| | | | September 30, 2013 | | | | December 31, 2012 |
| | | | (unaudited) | | | | |
|
Real estate properties, net
| | | |
$
|
767,408
| | | | |
$
|
535,390
|
|
Mortgage and other notes receivable, net
| | | |
59,367
| | | | |
84,250
|
|
Investment in preferred stock, at cost
| | | |
38,132
| | | | |
38,132
|
|
Cash and cash equivalents
| | | |
7,450
| | | | |
9,172
|
|
Marketable securities
| | | |
13,577
| | | | |
12,884
|
|
Straight-line rent receivable
| | | |
16,778
| | | | |
12,370
|
|
Equity-method investment and other assets
| | | |
14,402
| | | | |
12,172
|
|
Assets held for sale, net
| | | |
—
| | | | |
1,611
|
|
Debt
| | | |
391,362
| | | | |
203,250
|
|
National Health Investors Stockholders' equity
| | | |
479,702
| | | | |
457,182
|

National Health Investors, Inc.
Roger R. Hopkins, 615-890-9100
Chief
Accounting Officer
Source: National Health Investors, Inc.